To explore the cisplatin‐sensitivity of breast cancer cells knocked‐down ATP7A by siRNA, first, MDA‐MB‐231 cells were transfected with si‐ATP7A to achieve ATP7A knockdown, as verified using western blot (Figure 2A). Here, ATP7A is linked to breast carcinoma.